BPC-157 / TB-500 Blend
A research blend of two peptides studied for tissue-repair signalling: BPC-157 (a synthetic gastric pentadecapeptide) and TB-500 (a synthetic fragment of thymosin beta-4).
Customers also frequently order with
What research has studied about BPC-157 / TB-500 Blend
This blend combines two peptides that are frequently studied together in tissue-repair research. BPC-157 is a synthetic pentadecapeptide derived from a protein sequence found in gastric juice; TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring protein involved in cell migration and tissue organization.
In laboratory and animal-model studies, BPC-157 has been characterized for effects on angiogenesis and connective-tissue repair signalling, and thymosin beta-4 / TB-500 for roles in cell migration and wound-repair models. These are preclinical findings reported in the literature; nothing here describes use in humans.
Certificate of Analysis
A representative third-party certificate for BPC-157 / TB-500 Blend. Every batch ships with a lot-matched COA; contact us for the certificate on any other lot.
Specifications
| Compound | BPC-157 / TB-500 Blend |
| Available sizes | 10 mg |
| Form | Lyophilized powder |
| Purity | Measured by HPLC; see the Certificate of Analysis for the lot |
| Storage | Store cold and away from light per your lab protocol |
| Intended use | Laboratory and research use only |
Research sources
- Sikiric P, et al., "Stable gastric pentadecapeptide BPC 157 and tendon healing," J. Appl. Physiol. 110(3):648–653 (2011). PMID 21030672
- Chang CH, et al., "The promoting effect of pentadecapeptide BPC 157 on tendon healing," J. Orthop. Res. 29(6):961–968 (2011). PMID 20225319
- Goldstein AL, et al., "Thymosin beta4: a multi-functional regenerative peptide," Ann. N.Y. Acad. Sci. 1269:1–12 (2012). PMID 23045966
- Malinda KM, et al., "Thymosin beta4 accelerates wound healing," J. Invest. Dermatol. 113(3):364–368 (1999). PMID 10469335
Frequently asked questions
What is the BPC-157 / TB-500 blend?
It is a research blend of two synthetic peptides — BPC-157 and TB-500 — commonly studied together in tissue-repair research. Steadfast supplies it as a lyophilized research material for laboratory use only.
What has research studied about these peptides?
Preclinical studies have characterized BPC-157 in angiogenesis and connective-tissue models and thymosin beta-4/TB-500 in cell-migration and wound-repair models — laboratory and animal-model observations only.
Is it intended for human use?
No. It is a research chemical for in-vitro laboratory research only, not a drug or supplement.